Connection

WILLIAM HUDSON to Programmed Cell Death 1 Receptor

This is a "connection" page, showing publications WILLIAM HUDSON has written about Programmed Cell Death 1 Receptor.
  1. Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection. Immunity. 2019 12 17; 51(6):1043-1058.e4.
    View in: PubMed
    Score: 0.598
  2. CD7 regulates the persistence of terminally exhausted CD8+ T cells during chronic infection. Cell Rep. 2025 Oct 28; 44(10):116316.
    View in: PubMed
    Score: 0.224
  3. PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors. Sci Immunol. 2023 08 04; 8(86):eadg0539.
    View in: PubMed
    Score: 0.193
  4. mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infection. J Clin Invest. 2023 01 17; 133(2).
    View in: PubMed
    Score: 0.186
  5. PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program. Nature. 2022 10; 610(7930):173-181.
    View in: PubMed
    Score: 0.182
  6. PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection. Proc Natl Acad Sci U S A. 2020 02 25; 117(8):4292-4299.
    View in: PubMed
    Score: 0.151
  7. TGF-? regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection. J Exp Med. 2022 10 03; 219(10).
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.